1988 Help me understand this report
Use of Okt3 Monoclonal Antibody in the Treatment of Acute Cardiac Allograft Rejection
Search citation statements
Paper Sections
Select...
Citation Types
0
1
0
Year Published
1990
2005
Publication Types
Select...
4
1
Relationship
0
5
Authors
Journals
Cited by 8 publications
(1 citation statement)
References 0 publications
0
1
0
“…In adult studies, OKT3 has been shown to be efficacious in the management of steroid-resistant rejection. [2][3][4][5] In addition, use of OKT3 was associated with reversal of TxCAD in 1 study. 6 Although OKT3 is used in a number of pediatric heart transplant centers for induction therapy, less is known about its safety and efficacy in the management of graft dysfunction related to rejection.…”
mentioning
confidence: 99%
“…In adult studies, OKT3 has been shown to be efficacious in the management of steroid-resistant rejection. [2][3][4][5] In addition, use of OKT3 was associated with reversal of TxCAD in 1 study. 6 Although OKT3 is used in a number of pediatric heart transplant centers for induction therapy, less is known about its safety and efficacy in the management of graft dysfunction related to rejection.…”
mentioning
confidence: 99%
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
